Corindus Vascular Robotics has announced that a complex percutaneous coronary intervention (PCI) was broadcast live to attendees of the 2015 Complex Cardiovascular Catheter Therapeutics Conference (C3 Conference; 14–18 June, Orlando, USA).
Interventional cardiologists from around the world watched Arif Al Nooryani perform the triple-vessel disease case robotically in real-time by deploying bioresorbable stents, wiring the lesion and placing the stents using the CorPath system.
During the procedure, Al Nooryani, chief executive officer and head of the Cardiology Department at Al Qassimi Hospital, Sharjah, United Arab Emirates, sat in the CorPath system’s radiation-shielded interventional cockpit and did not need to wear a lead apron as he advanced the guidewires, balloons, and stents without being exposed to the hazards of X-ray radiation.
“This case showed how robotic technology is effective in the treatment of patients with complex disease, while protecting me from the occupational hazards of the cath lab,” said Al Nooryani. “The enhanced visualisation and precision provided by the CorPath system enabled me to place the bioresorbable vascular scaffold with optimal results for my patient.”
The CorPath system is the first FDA-cleared medical device to bring robotic-assisted precision to coronary interventional procedures. The CorPath system is currently indicated in the USA only for percutaneous coronary interventions.
